今天要介绍的CANCER GENE THERAPY,在行业里口碑超棒,大家都挺认可。 国人发文数量排第一,占比达到一半。影响因子连续多年往上涨,发展势头很猛。好多投稿的人都说过程挺愉快的,还收病例报告,临床医生可投。 01 期刊简介 CANCER GENE THERAPY于1999年创刊,保持每月出版一期。发表基因转移,基因治疗和细胞治疗领域的实验...
1. SCI影响因子及分区 2019年JCR公布的CANCER GENE THERAPY的影响因子为4.534。 图2 2015-2019五年间CANCER GENE THERAPY影响因子的变化(来源:Web of Science) 根据中科院大类分区为:医学2区;小类分区为:肿瘤学 3区|医学:研究与实验 2区|遗传学 2区|生物工程与应用微生物 2区。 图3 2020年CANCER GENE THERA...
搞科研期刊提供最新、最全的可以期刊查询,提供的期刊信息包括Impact Factor,期刊出版号,期刊官方投稿网址,研究方向,SCI期刊分区,中国作者发表的文章,投稿经验等。
投稿网址:http://mts-cgt.nature.com/cgi-bin/main.plex 英文简介 Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy as applied to cancer research. Types of manuscripts considered include: Original ...
期刊投稿网址 https://mts-cgt.nature.com/ 收稿范围 Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laborato...
期刊主页 cancer gene therapy主页 期刊评价 您选择的cancer gene therapy的指数解析如下: 简介:CANCER GENE THER杂志属于医学行业,“生物工程与应用微生物”子行业的优秀级杂志。投稿难度评价:中等偏上杂志,要求也较高,此区杂志很多,但是投中,并不容易 审稿速度:较慢,6-12周级别/热度:暗红评语:杂志级别不错,但...
期刊评价 您选择的cancer gene therapy的指数解析如下: 简介:CANCER GENE THER杂志属于医学行业,“生物工程与应用微生物”子行业的优秀级杂志。投稿难度评价:中等偏上杂志,要求也较高,此区杂志很多,但是投中,并不容易 审稿速度:较慢,6-12周级别/热度:暗红评语:杂志级别不错,但是比较冷门,关注人数偏少。 说明:指...
BMC Medical Genomics医学遗传学2.568N/A1755-8794 CLINICAL DYSMORPHOLOGY医学遗传学0.76N/A0962-8827 CLINICAL GENETICS医学遗传学4.104N/A0009-9163 CURRENT GENE THERAPY医学遗传学2.218N/A1566-5232 European Journal of Medical Genetics医学遗传学2.0224区1769-7212...
cancer gene therapy, cell-based therapies, and other forms of immunotherapies. The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments. Cancer Biotherapy and Radiopharmaceuticals ...
with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and ...